Solid Biosciences Llc Stock Investor Sentiment
| SLDB Stock | USD 4.70 0.12 2.49% |
About 63% of Solid Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Solid Biosciences LLC suggests that many traders are alarmed. The current market sentiment, together with Solid Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Solid Biosciences LLC stock news signals to limit their universe of possible portfolio assets.
Comfort Level 37
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Solid Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Solid Biosciences LLC.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Solid Historical Sentiment
Although Solid Biosciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Solid, such as negative comments on social media and news outlets, may cause fear in the market and push Solid Biosciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Solid.
Solid |
Solid Biosciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Solid Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Solid Biosciences LLC Historical Investor Sentiment
Investor biases related to Solid Biosciences' public news can be used to forecast risks associated with an investment in Solid. The trend in average sentiment can be used to explain how an investor holding Solid can time the market purely based on public headlines and social activities around Solid Biosciences LLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Solid Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Solid Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Solid Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Solid Biosciences.
Far too much social signal, news, headlines, and media speculation about Solid Biosciences that are available to investors today. That information is available publicly through Solid media outlets and privately through word of mouth or via Solid internal channels. However, regardless of the origin, that massive amount of Solid data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Solid Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Solid Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Solid Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Solid Biosciences alpha.
Solid Biosciences Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 3255 shares by Smith Ian F of Solid Biosciences subject to Rule 16b-3 | 01/03/2025 |
2 | Disposition of 11250 shares by Tan Kevin of Solid Biosciences subject to Rule 16b-3 | 01/08/2025 |
3 | Disposition of 388 shares by Ilan Ganot of Solid Biosciences subject to Rule 16b-3 | 01/27/2025 |
4 | Disposition of 144 shares by Ilan Ganot of Solid Biosciences at 3.1096 subject to Rule 16b-3 | 01/28/2025 |
5 | Disposition of 1142 shares by Ilan Ganot of Solid Biosciences at 5.2999 subject to Rule 16b-3 | 01/30/2025 |
6 | Acquisition by Alexander Cumbo of 401600 shares of Solid Biosciences subject to Rule 16b-3 | 01/31/2025 |
7 | Acquisition by Jessie Hanrahan of 110500 shares of Solid Biosciences subject to Rule 16b-3 | 02/11/2025 |
8 | Acquisition by Ilan Ganot of 3883 shares of Solid Biosciences subject to Rule 16b-3 | 02/12/2025 |
9 | Disposition of 4861 shares by Ilan Ganot of Solid Biosciences subject to Rule 16b-3 | 02/13/2025 |
10 | Disposition of 1711 shares by Ilan Ganot of Solid Biosciences at 3.96 subject to Rule 16b-3 | 02/14/2025 |
11 | Solid Biosciences Announces Pricing of Underwritten Offering | 02/18/2025 |
12 | Acquisition by Ra Capital Management, L.p. of 3722085 shares of Solid Biosciences at 0.001 subject to Rule 16b-3 | 02/19/2025 |
13 | Acquisition by Freed Martin I of 34400 shares of Solid Biosciences at 7.51 subject to Rule 16b-3 | 02/28/2025 |
14 | Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 03/04/2025 |
15 | Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides ... | 03/06/2025 |
16 | SLDB Stock Rallies 60 percent in a Month Heres What You Should Know | 03/07/2025 |
17 | Acquisition by Kahn Clare of 1860 shares of Solid Biosciences at 5.3357 subject to Rule 16b-3 | 03/11/2025 |
18 | Solid Biosciences to Present at the 2025 Muscular Dystrophy Association Clinical Scientific Conference | 03/12/2025 |
19 | Acquisition by Howton David T of 58750 shares of Solid Biosciences subject to Rule 16b-3 | 03/14/2025 |
20 | Solid Biosciences Inc.s market cap dropped US53m last week Private equity firms bore the brunt | 03/19/2025 |
Complementary Tools for Solid Stock analysis
When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |